Law360, New York (July 05, 2011, 11:57 AM ET) -- Immucor Inc., which makes automated instrument-reagent systems for the blood banking industry, said Tuesday it is being taken private by TPG Capital for $27 per share, or just less than $2 billion, with the private equity buyer hoping to expand the business.
The Texas-based global private equity group will commence an offer for shares of the Norcross, Ga.-based Immucor by July 15, and the deal requires 84 percent of shares to be tendered. Immucor has the option to shop for a better offer until Aug. 15...
Ropes Reps TPG In $2B Bid To Take Immucor Private
To view the full article, take a free trial now.
